These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 8626863

  • 1. The inhibitory effects of growth hormone-releasing hormone (GHRH)-antagonist on GHRH, L-dopa, and clonidine-induced GH secretion in normal subjects.
    Hanew K, Tanaka A, Utsumi A, Sugawara A, Abe K.
    J Clin Endocrinol Metab; 1996 May; 81(5):1952-5. PubMed ID: 8626863
    [Abstract] [Full Text] [Related]

  • 2. The role of endogenous GHRH in arginine-, insulin-, clonidine- and l-dopa-induced GH release in normal subjects.
    Hanew K, Utsumi A.
    Eur J Endocrinol; 2002 Feb; 146(2):197-202. PubMed ID: 11834428
    [Abstract] [Full Text] [Related]

  • 3. Variable plasma growth hormone (GH)-releasing hormone and GH responses to clonidine, L-dopa, and insulin in normal men.
    Tapanainen P, Knip M, Lautala P, Leppäluoto J.
    J Clin Endocrinol Metab; 1988 Oct; 67(4):845-9. PubMed ID: 3138280
    [Abstract] [Full Text] [Related]

  • 4. Endogenous growth hormone (GH)-releasing hormone is required for GH responses to pharmacological stimuli.
    Jaffe CA, DeMott-Friberg R, Barkan AL.
    J Clin Invest; 1996 Feb 15; 97(4):934-40. PubMed ID: 8613546
    [Abstract] [Full Text] [Related]

  • 5. Growth hormone releasing hormone 1-44 NH2 and 1-40 OH levels in normal subjects during growth hormone stimulation tests.
    Page MD, Dieguez C, Valcavi R, Koppeschaar HP, Scanlon MF.
    Clin Endocrinol (Oxf); 1994 Jan 15; 40(1):97-102. PubMed ID: 8306488
    [Abstract] [Full Text] [Related]

  • 6. Impaired inhibitory effects of somatostatin on growth hormone (GH)-releasing hormone stimulation of GH secretion after short term infusion.
    Kelijman M, Frohman LA.
    J Clin Endocrinol Metab; 1990 Jul 15; 71(1):157-63. PubMed ID: 1973420
    [Abstract] [Full Text] [Related]

  • 7. Alpha 2-adrenergic agonism enhances the growth hormone (GH) response to GH-releasing hormone through an inhibition of hypothalamic somatostatin release in normal men.
    Devesa J, Arce V, Lois N, Tresguerres JA, Lima L.
    J Clin Endocrinol Metab; 1990 Dec 15; 71(6):1581-8. PubMed ID: 1977761
    [Abstract] [Full Text] [Related]

  • 8. Corticotropin-releasing hormone inhibition of growth hormone-releasing hormone-induced growth hormone release in man.
    Barbarino A, Corsello SM, Della Casa S, Tofani A, Sciuto R, Rota CA, Bollanti L, Barini A.
    J Clin Endocrinol Metab; 1990 Nov 15; 71(5):1368-74. PubMed ID: 2229294
    [Abstract] [Full Text] [Related]

  • 9. Acute effects of clonidine and growth-hormone-releasing hormone on growth hormone secretion in patients with hyperthyroidism.
    Giustina A, Buffoli MG, Bussi AR, Wehrenberg WB.
    Horm Res; 1991 Nov 15; 36(5-6):192-5. PubMed ID: 1823078
    [Abstract] [Full Text] [Related]

  • 10. Nocturnal growth hormone (GH) secretion is eliminated by infusion of GH-releasing hormone antagonist.
    Ocampo-Lim B, Guo W, DeMott-Friberg R, Barkan AL, Jaffe CA.
    J Clin Endocrinol Metab; 1996 Dec 15; 81(12):4396-9. PubMed ID: 8954048
    [Abstract] [Full Text] [Related]

  • 11. Evidence that alpha 2-adrenergic pathways play a major role in growth hormone (GH) neuroregulation: alpha 2-adrenergic agonism counteracts the inhibitory effect of muscarinic cholinergic receptor blockade on the GH response to GH-releasing hormone, while alpha 2-adrenergic blockade diminishes the potentiating effect of increased cholinergic tone on such stimulation in normal men.
    Devesa J, Diaz MJ, Tresguerres JA, Arce V, Lima L.
    J Clin Endocrinol Metab; 1991 Aug 15; 73(2):251-6. PubMed ID: 1677361
    [Abstract] [Full Text] [Related]

  • 12. Interaction of L-dopa and GHRH on GH secretion in normal men.
    Alba-Roth J, von Creytz C, Mehltretter G, Schopohl J, Müller OA, von Werder K.
    J Endocrinol Invest; 1989 Dec 15; 12(11):783-7. PubMed ID: 2515218
    [Abstract] [Full Text] [Related]

  • 13. Pyridostigmine blocks the inhibitory effect of glucocorticoids on growth hormone-releasing hormone stimulated growth hormone secretion in normal man.
    Giustina A, Girelli A, Doga M, Bodini C, Bossoni S, Romanelli G, Wehrenberg WB.
    J Clin Endocrinol Metab; 1990 Sep 15; 71(3):580-4. PubMed ID: 2118535
    [Abstract] [Full Text] [Related]

  • 14. Comparative effect of clonidine and growth hormone (GH)-releasing hormone on GH secretion in adult patients on chronic glucocorticoid therapy.
    Giustina A, Buffoli MG, Bussi AR, Doga M, Girelli A, Pizzocolo G, Pozzi A, Wehrenberg WB.
    Horm Metab Res; 1992 May 15; 24(5):240-3. PubMed ID: 1398465
    [Abstract] [Full Text] [Related]

  • 15. Augmentation by propranolol of growth hormone-releasing hormone-(1-44)-NH2-induced growth hormone release in normal short and normal children.
    Chihara K, Kodama H, Kaji H, Kita T, Kashio Y, Okimura Y, Abe H, Fujita T.
    J Clin Endocrinol Metab; 1985 Aug 15; 61(2):229-33. PubMed ID: 2989315
    [Abstract] [Full Text] [Related]

  • 16. Cholinergic receptor activation by pyridostigmine restores growth hormone (GH) responsiveness to GH-releasing hormone administration in obese subjects: evidence for hypothalamic somatostatinergic participation in the blunted GH release of obesity.
    Cordido F, Casanueva FF, Dieguez C.
    J Clin Endocrinol Metab; 1989 Feb 15; 68(2):290-3. PubMed ID: 2493023
    [Abstract] [Full Text] [Related]

  • 17. Discordance between growth hormone (GH) responses after GH-releasing hormone and insulin hypoglycemia in myotonic dystrophy.
    Okimura Y, Chihara K, Kita T, Kashio Y, Sato M, Kitajima N, Abe H, Takahashi K, Fujita T.
    J Clin Endocrinol Metab; 1988 Nov 15; 67(5):1074-9. PubMed ID: 3141449
    [Abstract] [Full Text] [Related]

  • 18. Growth hormone (GH) responsiveness to combined administration of arginine and GH-releasing hormone does not vary with age in man.
    Ghigo E, Goffi S, Nicolosi M, Arvat E, Valente F, Mazza E, Ghigo MC, Camanni F.
    J Clin Endocrinol Metab; 1990 Dec 15; 71(6):1481-5. PubMed ID: 2229304
    [Abstract] [Full Text] [Related]

  • 19. The interaction between clonidine and growth hormone releasing hormone in the stimulation of growth hormone secretion in man.
    Suri D, Hindmarsh PC, Brain CE, Pringle PJ, Brook CG.
    Clin Endocrinol (Oxf); 1990 Sep 15; 33(3):399-406. PubMed ID: 2147600
    [Abstract] [Full Text] [Related]

  • 20. The decrease in growth hormone (GH) response after repeated stimulation with GH-releasing hormone is partly caused by an elevation of somatostatin tonus.
    Reichardt B, Schrader M, Mojto J, Mehltretter G, Müller OA, Schopohl J.
    J Clin Endocrinol Metab; 1996 May 15; 81(5):1994-8. PubMed ID: 8626871
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.